This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Agenus Inc., Ligand Pharmaceuticals, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Woburn, MA (US) (2021 - 2023)
- Lexington, MA (US) (2023)
Company Filing History:
Years Active: 2021-2026
Title: The Innovations of Dhan Sidhartha Chand in Antibody Development
Introduction
Dhan Sidhartha Chand is an inventive mind located in Woburn, MA, United States. He has made significant contributions to the field of biotechnology, with a notable portfolio of five patents that showcase his dedication to advancing medical science through innovative solutions.
Latest Patents
Chand's latest patents revolve around the development of multispecific antibodies targeting immune checkpoint receptors. These include the innovative Anti-TIGIT and anti-CD96 antibodies, which are designed to bind specifically to human CD96 and TIGIT. The disclosures detail the creation of pharmaceutical compositions that incorporate these multispecific molecules and antibodies, along with nucleic acids, expression vectors, and host cells to facilitate their production. Furthermore, these inventions outline methods for treating subjects using these advanced therapies, which hold the potential to enhance cancer treatment by modulating immune responses.
Chand has also developed antibodies that specifically bind to human CD96, serving to antagonize CD96 functions. This innovation includes comprehensive pharmaceutical compositions, nucleic acids for encoding the antibodies, and methodologies for treating individuals using these targeted therapies.
Career Highlights
Dhan Sidhartha Chand is actively engaged with Agenus Inc., a company known for its pioneering work in immuno-oncology. His role in developing cutting-edge antibody therapies highlights his status as a leading inventor in the biotech sector. Chand's work reflects a commitment to creating advanced medical solutions that could play a crucial role in therapeutic applications.
Collaborations
Throughout his career, Chand has collaborated with talented professionals in the field, including Benjamin Maxime Morin and Olga Ignatovich. These partnerships exemplify the collaborative spirit prevalent in research and development, leading to innovative breakthroughs and advancements in biotechnology.
Conclusion
Dhan Sidhartha Chand's contributions to biotechnology, particularly in the realm of antibody development, underscore his innovative approach to addressing complex medical challenges. His patents not only reflect his expertise but also his potential to impact the future of immunotherapy, making him a noteworthy inventor in the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile